ASSEMBLY, No. 446

STATE OF NEW JERSEY

215th LEGISLATURE

 

PRE-FILED FOR INTRODUCTION IN THE 2012 SESSION

 


 

Sponsored by:

Assemblywoman  MARY PAT ANGELINI

District 11 (Monmouth)

Assemblyman  NELSON T. ALBANO

District 1 (Atlantic, Cape May and Cumberland)

Assemblyman  GORDON M. JOHNSON

District 37 (Bergen)

 

Co-Sponsored by:

Assemblywoman Handlin, Assemblymen Rudder and Chiusano

 

 

 

 

SYNOPSIS

     Adds certain cannabis-like chemical substances to list of controlled dangerous substances.

 

CURRENT VERSION OF TEXT

     Introduced Pending Technical Review by Legislative Counsel

  


An Act concerning controlled dangerous substances and amending P.L.1970, c.226.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    Section 5 of P.L.1970, c.226 (C.24:21-5) is amended to read as follows:

     5.    Schedule I.

     a.     Tests. The director shall place a substance in Schedule I if he finds that the substance:  (1) has high potential for abuse; and (2) has no accepted medical use in treatment in the United States; or lacks accepted safety for use in treatment under medical supervision.

     b.    The controlled dangerous substances listed in this section are included in Schedule I, subject to any revision and republishing by the director pursuant to subsection d. of section 3 of P.L.1970, c.226 (C.24:21-3), and except to the extent provided in any other schedule.

     c.     Any of the following opiates, including their isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:

     (1)   Acetylmethadol

     (2)   Allylprodine

     (3)   Alphacetylmethadol

     (4)   Alphameprodine

     (5)   Alphamethadol

     (6)   Benzethidine

     (7)   Betacetylmethadol

     (8)   Betameprodine

     (9)   Betamethadol

     (10) Betaprodine

     (11) Clonitazene

     (12) Dextromoramide

     (13) Dextrorphan

     (14) Diampromide

     (15) Diethylthiambutene

     (16) Dimenoxadol

     (17) Dimepheptanol

     (18) Dimethylthiambutene

     (19) Dioxaphetyl butyrate

     (20) Dipipanone

     (21) Ethylmethylthiambutene

     (22) Etonitazene

     (23) Etoxeridine

     (24) Furethidine

     (25) Hydroxypethidine

     (26) Ketobemidone

     (27) Levomoramide

     (28) Levophenacylmorphan

     (29) Morpheridine

     (30) Noracymethadol

     (31) Norlevorphanol

     (32) Normethadone

     (33) Norpipanone

     (34) Phenadoxone

     (35) Phenampromide

     (36) Phenomorphan

     (37) Phenoperidine

     (38) Piritramide

     (39) Proheptazine

     (40) Properidine

     (41) Racemoramide

     (42) Trimeperidine.

     d.    Any of the following narcotic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

     (1)   Acetorphine

     (2)   Acetylcodone

     (3)   Acetyldihydrocodeine

     (4)   Benzylmorphine

     (5)   Codeine methylbromide

     (6)   Codeine-N-Oxide

     (7)   Cyprenorphine

     (8)   Desomorphine

     (9)   Dihydromorphine

     (10) Etorphine

     (11) Heroin

     (12) Hydromorphinol

     (13) Methyldesorphine

     (14) Methylhydromorphine

     (15) Morphine methylbromide

     (16) Morphine methylsulfonate

     (17) Morphine-N-Oxide

     (18) Myrophine

     (19) Nicocodeine

     (20) Nicomorphine

     (21) Normorphine

     (22) Phoclodine

     (23) Thebacon.

     e.     Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

     (1)   3,4-methylenedioxy amphetamine

     (2)   5-methoxy-3,4-methylenedioxy amphetamine

     (3)   3,4,5-trimethoxy amphetamine

     (4)   Bufotenine

     (5)   Diethyltryptamine

     (6)   Dimethyltryptamine

     (7)   4-methyl-2,5-dimethoxylamphetamine

     (8)   Ibogaine

     (9)   Lysergic acid diethylamide

     (10) Marihuana

     (11) Mescaline

     (12) Peyote

     (13) N-ethyl-3-piperidyl benzilate

     (14) N-methyl-3-piperidyl benzilate

     (15) Psilocybin

     (16) Psilocyn

     (17) Tetrahydrocannabinols

     (18) (6aR,10aR)-9 - (hydroxymethyl) - 6, 6 - dimethyl - 3 - (2

     methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol

     Some trade or other names: HU-210

     (19) 1-Pentyl-3-(1-naphthoyl)indole.  Some trade or other names:    JWH-018

     (20) 1-Butyl-3-(1-naphthoyl)indole. Some trade or other names:

     JWH-073.

(cf: P.L.2007, c.244, s.3)

 

     2.    This act shall take effect immediately.

 

 

STATEMENT

 

     This bill would add three chemical compounds, HU-210, JWH-018 and JWH-073 to the list of prohibited schedule I drugs.  These substances have been mixed with plant based products and marketed as synthetic marijuana, "Spice" or "K2."  Some users have reported that products containing these substances have effects similar to the effects of cannabis.

     The most severe controlled substance penalties involve drugs listed in schedule I.  Schedule I drugs have a high potential for abuse and no accepted medical use, and include heroin, LSD.